Gum disease and osteoporosis: hidden link in older women?
NCT ID NCT07294105
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examined 80 postmenopausal women to see if there is a connection between gum (periodontal) disease and osteoporosis. Researchers measured two substances in blood and gum fluid called sclerostin and TNF-α, which may help explain how these conditions affect each other. The goal was to gather knowledge, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
80 people
The number who actually took part.
- Started
-
Nov 2022
- Finished
-
May 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Postmenopausal female patients applying to the Periodontics Clinic of Recep Tayyip Erdoğan University Faculty of Dentistry
- Ages
-
43 to 78 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female patients aged 40 years and older in the postmenopausal period, * Individuals diagnosed with osteoporosis or healthy individuals without osteoporosis, as determined by DXA testing of the hip or spine, * Individuals who had been postmenopausal for ≥6 months and had not received hormone replacement therapy, * Patients who did not smoke or consume alcohol, * Female patients who were periodontally healthy or diagnosed with Stage 2-3, Grade A periodontitis Exclusion Criteria: * Patients with chronic renal and hepatic insufficiency; malignant diseases such as diabetes mellitus, leukemia, multiple myeloma, and widespread carcinoma; chronic inflammatory rheumatic diseases such as rheumatoid arthritis and ankylosing spondylitis; and those using drugs that may affect bone metabolism (glucocorticoids, heparin, methotrexate, anticonvulsants), * Those who had received antibiotic therapy in the previous 3 months or any medication for osteoporosis treatment, * Patients who had undergone surgical or non-surgical periodontal treatment within the previous 6 months, * Patients who did not wish to continue participation in the study at the midpoint or at the end of the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Periodontal disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Recep Tayyip Erdoğan University
Rize, Rize Province, 53020, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Magnifying the fight against gum disease: loupe vs microscope
- Can teaching people with diabetes to care for their gums also help their blood sugar?
- Could a toothbrush and mouthwash cut pneumonia in the elderly?
- Can a laser boost the power of gum surgery?
- Can a Two-Step mouthwash and toothpaste routine boost gum healing?
- Gum fluid proteins may hold clues to periodontal disease severity